BRKA

Growing Competitive Pressures, Leverage Drive Our Reduced Fair Value Estimate of CVS Health (Walgreens, Too)

by

By Callum Turcan On November 9, we reduced our fair value estimate of CVS Health Corporation (CVS) (which operates pharmacies, walk-in medical clinics, retail centers, and a large health insurance business). Our new fair value estimate is $55 per share, down from $73 per share previously. CVS Health’s 52-week share price range has been $52-$77, and the company yields 2.7% at the time of this writing. We recently wrote an article here explaining some of the major broad-based drivers behind why fair value estimates can, do, and should change over time as future expectations change. From our perspective, CVS Health’s near- and medium-term outlook has become increasingly stressed. Though investors have bid up shares of CVS in the wake of … Read more

Reiterating Our $229 Fair Value Estimate for Berkshire Hathaway

by

Image Shown: Shares of Berkshire Hathaway Inc Class B are moving on upwards. Berkshire Hathaway Inc reported third quarter 2020 earnings this past Saturday, November 7. The insurance and industrial conglomerate reported that its GAAP income almost doubled year-over-year as its investment portfolio reported large gains. However, that masked pressures at some of Berkshire Hathaway’s myriad businesses as the company navigated the storm created by the ongoing coronavirus (‘COVID-19’) pandemic. Berkshire Hathaway continued to generate significant free cash flows during the first nine months of 2020, and we are reiterating our fair value estimate of $229 per share of Berkshire Hathaway Class B shares. By Callum Turcan On November 7, Berkshire Hathaway Inc (BRK.A) (BRK.B) reported third quarter earnings for … Read more

Best Ideas Newsletter Portfolio Holdings Are Surging!

by

Image: The holdings in the Best Ideas Newsletter during the trading session November 4. We continue to pound the table on our best ideas. By Brian Nelson, CFA If you were like me, you stayed up as long as you could last night watching the U.S. election coverage before it became too difficult to keep your eyes open. When I went to sleep, it seemed as though Donald Trump would be re-elected. The only state that appeared to flip to the Democrats from the 2016 election was Arizona, meaning Trump would still retain greater than the 270 electoral votes required to gain re-election. Well, that was last night, and this is today. As more and more votes came in last … Read more

Kraft Heinz Shows the Power of the VBI

by

Image: Years ago, shares of Kraft Heinz registered a rating of 1 on the Valuentum Buying Index (VBI) on two separate occasions, highlighting the company’s overpriced nature and weakening technicals. Rare and extreme ratings on the VBI, 1 = worst; 10 = best, tend to be the most informative and/or the most actionable for investors.    There are just too many net cash rich, free cash flow generating powerhouses with tremendous competitively advantaged business models tied to secular growth tailwinds that taking a flier on an overleveraged turnaround such as Kraft Heinz almost feels irresponsible. That said, shares yield ~5.2% as of this writing, so income investors might find a decent risk reward at the right price. With a 27% stake, … Read more

Great Day in the Markets!

by

Image: The Invesco QQQ Trust, an exchange-traded fund based on the NASDAQ 100 index, had a great day during the trading session October 12, as it leads all major indexes on the year.  — By Brian Nelson, CFA — First of all, a warm welcome to our new members. We recently posted a website overview video on our website here, and please be sure to view our stock report walk-through . At Valuentum, we’re financial publishers, so please be sure to read through how many members use our services here. — The trading session October 12 was a sight to see. The Dow Jones Industrial Average advanced 0.88%, the S&P 500 jumped 1.64%, while the NASDAQ powered ahead an incredible 2.56%. As many of our … Read more

The Merits of Concentrated Portfolios

by

My dear friends: — Many thanks for your continued interest in our work.  — Though uncertainty in the efficacy of any vaccine for coronavirus disease (“COVID-19”) remains, the New York Times reported today that the CDC “has notified public health officials in all 50 states and five large cities to prepare to distribute a coronavirus vaccine to health care workers and other high-risk groups as soon as late October or early November,” just weeks from now.  — While expected by the optimists, we continue to view this as good news. The sheer amount of resources, both public and private, seeking a vaccine for COVID-19 leads me to believe we’ll have one sooner than later, in time to set the economy up for a stronger-than-expected … Read more

Berkshire Hathaway Is Finally Putting Its Enormous Cash Pile to Use

by

Image Shown: Shares of Berkshire Hathaway Inc Class B are recovering from the steep pandemic-induced fall as the company has started to put its enormous cash-pile to work. By Callum Turcan On August 31, Berkshire Hathaway Inc (BRK.A) (BRK.B) announced it had  “acquired slightly more than 5% of the outstanding shares in five of the leading Japanese trading companies” and that the firm considered these to be “passive stakes.” Those positions were acquired over approximately the past year through purchases made on the Tokyo Stock Exchange. Here are the five companies in alphabetical order (by ticker): Itochu Corporation (ITOCF), Marubeni Corporation (MARUF), Mitsui & Co. Ltd. (MITSF), Mitsubishi Corporation (MSBHF), and Sumitomo Corporation (SSUMY). Berkshire As of June 30, 2020, … Read more

Just How Good Have We Been?

by

Image: We have been absolutely pounding the table on big cap tech and large cap growth for many months now. It has been one of the rare buckets to have done well this year. By well, we mean superb. Source: Zerohedge — Hi everyone:—Brian here. Just how good have we been for members? — After capping off one of the best years in the Best Ideas Newsletter portfolio in 2019, we highlighted broad market put option ideas in late February and early March–right before the COVID-19 crash that shocked the markets.  — Then, just about right near the bottom, we highlighted 17 of 20 outperforming ideas–strong net-cash-rich, free-cash-flow generating powerhouses with strong secular growth tailwinds. We then went all-in in the newsletter … Read more

ALERT: Newsletter Portfolio Changes; Investing Is Simple, Not Easy

by

Changes to the Newsletter portfolios Best Ideas Newsletter portfolio BRK.B: 8-13% à 3.5%-5% AAPL: 4.2%-6% à 6.5%-8% MSFT: 4.2%-6% à 6.5%-8% Dividend Growth Newsletter portfolio BKLN: 4.25%-6.5% à 0% KMI: 3.25%-4.25% à 0% LMT: 3.25%-4.5% à 6.25%-8.5% ORCL: 4.25%-6.5% à 6.25%-8.5% AAPL: 2.75%-4% à 3.25%-4.5% MSFT: 2.75%-4% à 6.25%-8.5% —– Hi everyone: Trust you are doing great. I wanted to let you know of a few newsletter portfolio changes we’re making today. In the Best Ideas Newsletter portfolio, we are reducing the position in Berkshire Hathaway (BRK.B) to the weighting range of 3.5%-5% from 8%-13%. Though we think Warren Buffett is getting back on track now that he has dumped the airlines and many of the banks, we no longer … Read more

August Best Ideas Newsletter!

by

Image: The Best Ideas Newsletter portfolio. We migrated to weighting ranges at the beginning of 2018. The image above is as of the close April 15. — Hi everyone: — Trust you are well.  — Portfolio concentration among strong-performing equities has been the key to outperformance. Since the last update, we’ve witnessed some big moves from our top-weighted entities: Berkshire Hathaway (+10.7%), Facebook (+8.7%), and PayPal (+11.2%). These three entities comprise roughly 34% of the Best Ideas Newsletter portfolio at the high end of the weighting ranges, more than offsetting the weaker performance from lower-weighted Cisco and Intel during the month. We continue to focus on over-weighting our “best of the best” ideas within a portfolio setting, and we’re hoping to … Read more